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Abstract Ras GTPases are binary switches, cycling between
an inactive GDP-bound form and an active GTP-bound form at
the membrane. They transduce signals into the cytoplasm via
e¡ector pathways that regulate cell growth, di¡erentiation and
apoptosis. Ras activation is enhanced by guanine nucleotide ex-
change factors (GEFs); deactivation is accelerated by GTP-
ase-activating proteins (GAPs). Recently, new roles for Ca2+
and diacylglycerol (DAG) in the control of Ras cycling have
emerged with the discovery of a series of novel GEFs and
GAPs. These regulators of Ras cycling are likely to play a
key role in the information processing of Ca2+ and DAG sig-
nals.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Three human ras genes encode four proteins (H-Ras, N-
Ras, K-Ras4A and K-Ras4B) that operate as binary molec-
ular switches, cycling between an inactive GDP-bound form
and an active GTP-bound form at the membrane [1]. They
transduce signals from cell surface receptors into the cyto-
plasm via speci¢c e¡ector pathways that regulate cell growth,
di¡erentiation and apoptosis [2^5]. In vitro Ras exhibits slow
rates of GDP/GTP exchange and GTP hydrolysis, thus the
relative fraction of cellular Ras in an active conformation
depends on the rates of these reactions [6]. Guanine nucleotide
exchange factors (GEFs) bind to Ras and markedly accelerate
the rate of GDP dissociation. In contrast, deactivation re-
quires the binding of GTPase-activating proteins (GAPs)
that signi¢cantly enhance the intrinsic Ras GTPase activity.
Overall the spatio-temporal regulation of GEFs and GAPs co-
ordinates Ras signalling events (Fig. 1). This integration of
Ras activation/deactivation is highly complex as there are
multiple Ras GEFs and Ras GAPs with variable tissue-spe-
ci¢c expression that are stimulated or inhibited ^ depending
on the nature of the signal.
Understanding how Ras activity is controlled during cell
stimulation is crucial considering the role oncogenic Ras plays
in tumorigenesis [5]. Mutant Ras proteins with speci¢c amino
acid substitutions that render the GTPase insensitive to GAP
stimulation are locked in the GTP-bound state resulting in
aberrant downstream signalling. Thus, oncogenic Ras is con-
stitutively active in transforming some (but not all [7]) mam-
malian cells and this is consistent with the fact that around
30% of human tumours contain activating Ras mutations [8].
Many receptor tyrosine kinases (RTKs) and G protein-
coupled receptors (GPCRs) are linked to the hydrolysis of
phosphatidylinositol 4,5-bisphosphate by phospholipase C
(PLC) to generate inositol 1,4,5-trisphosphate (IP3) and dia-
cylglycerol (DAG). IP3 stimulates the release of the ubiqui-
tous second messenger Ca2þ from internal stores to regulate a
diverse set of cellular processes, with the versatility of calcium
signalling relying on the remarkable number of di¡erent
mechanisms for storage, release, propagation and removal
of intracellular ions. This results in the spatio-temporal pat-
terning of a Ca2þ response [9]. DAG production is classically
associated with the mitogenic actions of protein kinase C
(PKC) [10], however new targets for DAG have recently
been discovered including a speci¢c class of Ras GEFs
[11,12]. Ca2þ itself is known to play a key role in cell prolif-
eration and the regulation of the cell cycle [13], and growth
requires a functional intracellular Ca2þ store [14]. Historically,
there is a fundamental link between cell growth and a require-
ment for extracellular Ca2þ [15], which is also associated with
a role for Ras. For example, in the 1970s chemical and viral
transformation, including by Kirsten murine sarcoma virus
(encoding v-K-ras) [16], led to extracellular Ca2þ-independent
proliferation of transformed cells. Furthermore, Ras transfor-
mation was also shown to block Ca2þ-induced terminal dif-
ferentiation of mouse epidermal keratinocytes [17,18]. This
review concentrates on recent ¢ndings that provide new evi-
dence for direct and dynamic Ca2þ regulation of Ras cycling
by GEFs, GAPs and other control mechanisms.
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2. Ca2+- and DAG-dependent Ras GEFs
2.1. Guanine nucleotide-releasing factor (GRF) family
In 1994 a seminal study by Rosen et al. showed that Ca2þ
in£ux or store release activated Ras in PC12 cells and primary
cortical neurones [19]. Following this ¢nding came direct evi-
dence for Ca2þ-regulated Ras activity through the discovery
of a Ca2þ/calmodulin-dependent Ras GEF called Ras-GRF1
[20,21] (also known as CDC25Mm [22]) and a closely related
GEF, Ras-GRF2 [23]. The regulation and function of this
family of GEFs is complex and has been recently reviewed
elsewhere [12], therefore we will not discuss them in detail.
GRFs are not speci¢c GEFs for Ras; rather they are bi-
functional Ras and Rac GEFs that contain both a CDC25
homology exchange domain (for Ras) and a Dbl homology
exchange domain (for Rac). Multiple mechanisms for regulat-
ing GRF activation other than just by Ca2þ have been re-
ported [12] so it is currently unclear exactly how, when and
where these GEFs are activated to stimulate Ras or Rac sig-
nalling. Recent ¢ndings raise the possibility that Ras-GRF1 is
tethered to the IB2/c-Jun amino-terminal kinase interacting
protein 2 sca¡old to bring the GEF, Rac and an e¡ector,
mixed lineage kinase 3, into a spatially discrete complex to
stimulate the p38 signalling cascade [24]. GRF1 is highly ex-
pressed in brain tissue and the domains that mediate binding
to the sca¡old are also required for GEF activation by Ca2þ
[25], which may link Ca2þ in£ux through neuronal channels to
Ras/Rac signalling [24].
Mice lacking Ras-GRF1 have abnormal long-term poten-
tiation in the amygdala suggesting that GRF1 regulation of
Ras signalling has a role to play in synaptic plasticity [26].
This is an attractive hypothesis given the role of the mitogen-
activated protein kinase (MAPK) pathway in the control of
activity-dependent gene expression. Three independent lines of
knockout mice have been generated [26^28] resulting in some
dispute over the location of the learning and memory de¢cit
[26,28]. Two lines of mice had reduced body weight and re-
mained small during development [27,28]. This is likely to be
because grf1 is imprinted, with the ¢nding that the Itier et al.
mice had a de¢cit in growth hormone production [27]. In
contrast, GRF2-de¢cient mice are normal, and double grf1/
grf2 knockout animals are identical to the GRF1-de¢cient
phenotype in terms of growth and development [29]. GRF1-
de¢cient phenotypes could result from a defect in small
GTPase regulation, for example by Ca2þ, but no study has
yet demonstrated an impairment of Ras (or Rac) activation in
Ras-GRF1-de¢cient cells.
2.2. Guanyl nucleotide-releasing protein/calcium and
diacylglycerol-regulated guanine nucleotide exchange
factor (GRP/CalDAG-GEF) family
This is a family of four genes encoding ¢ve Ras/Rap GEFs,
viz. Ras-GRP/CalDAG-GEF II, CalDAG-GEF I, Ras-
GRP2, Ras-GRP3/CalDAG-GEF III and Ras-GRP4 (see
[12] for a detailed review). These GEFs appear to display
some sensitivity to Ca2þ regulation through EF-hand do-
mains, e.g. GRP, CalDAG-GEF I and GRP2 [30^32]. EF-
hand domains are present in many Ca2þ-binding proteins
and consist of a short Ca2þ-binding loop £anked on both
sides by helical domains. The GRP/CalDAG-GEFs also con-
tain a DAG-binding C1 domain in close proximity with the
twin EF-hand motifs, although there is no evidence that Ca2þ
and the EF-hands in£uence the DAG-binding activity of the
C1 domain [33]. In T cells where Ras-GRP is highly expressed
Ebinu et al. observed that Ras-GRP activated Ras in vivo
even in the presence of Ca2þ chelators [34]. Other studies
have used Ca2þ ionophores to manipulate intracellular Ca2þ
but this treatment can also evoke the production of DAG by
Ca2þ-dependent stimulation of PLC, therefore there is a ques-
tion mark regarding the physiological role of Ca2þ in the
activation of this family of GEFs. What is clear is that the
C1 domain is required to dynamically recruit the GRPs to the
plasma membrane in order to activate Ras [32,35,36], so it
seems likely that DAG plays a dominant role in second mes-
senger regulation of this gene family.
3. Ca2+-dependent Ras GAPs
Over the last decade substantial anecdotal evidence has ac-
cumulated for a potential Ca2þ-feedback loop within Ras-
MAPK signalling in a variety of di¡erent cell types [12].
The clearest evidence for the existence of Ca2þ-dependent
Ras deactivation has come from studies of keratinocytes. On-
cogenic Ras blocks Ca2þ-induced di¡erentiation [17,18] and
Ras is deactivated by Ca2þ in£ux in human keratinocytes
[37,38]. An explanation for transient Ca2þ-triggered deactiva-
tion of Ras would be through the action of Ca2þ-dependent
Ras GAPs and Medema et al. suggested a role for p120 Ras
GAP because it translocates to the keratinocyte membrane in
response to Ca2þ stimulation [39]. The mechanism for mem-
brane recruitment by Ca2þ could involve GAP-associated pro-
teins [39] or via an electrostatic interaction between the C2
domain of p120 Ras GAP and the membrane [40]. C2 do-
mains are known to be Ca2þ-dependent phospholipid-binding
domains in proteins such as conventional PKC and synapto-
tagmins.
A short, truncated version of the p120 Ras GAP C2 do-
main, the so-called CaLB motif, was shown to speci¢cally
bind phospholipids in a Ca2þ-dependent manner in vitro
[40,41], although others (E.A. Nalefski, University of Colora-
do, personal communication) have been unable to demon-
Fig. 1. The Ras GTPase cycle. The Ras activation state depends on
the action of GEFs and GAPs. Oncogenic Ras is locked in the
GTP-bound state and is resistant to the action of GAPs. Many Ras
e¡ectors such as Raf, RalGDS and phosphoinositide 3-kinase bind
to the active GTP-bound conformation to signal downstream.
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strate such an association with natural membranes using full-
length protein [42]. It is di⁄cult to resolve p120 Ras GAP as a
Ca2þ sensor because the C2 domain contains none of the
aspartate residues known to co-ordinate Ca2þ ions in other
Ca2þ-binding C2 domains [43]. Subsequently, it has also been
suggested that Ca2þ-independent association with annexin VI
might promote Ca2þ-triggered co-migration to the membrane
[44], therefore the potential role of p120 Ras GAP in Ca2þ-
dependent Ras regulation is still unclear. It is assumed that
Ca2þ-induced recruitment to the membrane increases the ef-
fectiveness of the GAP by localising within the vicinity of Ras
on the inner lea£et, in a similar manner to SH2 domain-de-
pendent association with RTKs. However, a direct increase in
cellular GAP activity by Ca2þ stimulation has yet to be con-
vincingly attributed to endogenous or expressed p120 Ras
GAP.
The prototypical Ca2þ-triggered Ras GAP is calcium-pro-
moted Ras inactivator (CAPRI) [45], a member of the GAP1
family that includes GAP1IP4BP, GAP1m and Ras GTPase-
activating-like (RASAL). Both CAPRI and RASAL contain
a pair of C2 domains (C2A and C2B) with a full set of ¢ve
putative Ca2þ-co-ordinating acidic residues [45]. CAPRI is
basally inactive and present in the cytosol of unstimulated
cells (Fig. 2). Agonist-evoked intracellular Ca2þ mobilisation
leads to the rapid, C2 domain-dependent translocation to the
plasma membrane (Fig. 2) that is paralleled by a signi¢cant
reduction in cellular Ras-GTP levels in CAPRI stable Chinese
hamster ovary (CHO) cell lines [45]. The CHO cells also have
abrogated extracellular signal-regulated kinase (ERK) signal-
ling downstream of GPCR stimulation but no inhibition of
ERK signalling downstream of a RTK which is not coupled
to PLC [45]. Although CAPRI has no detectable in vitro
activity using standard assays, cells expressing a GAP mutant
predicted to disrupt the Ras-GTP/GAP interaction have nor-
mal ERK signalling [45]. Furthermore, using a £uorescent
chimera of the Ras-binding domain from Raf (GFP-RBD)
and live cell imaging, we have con¢rmed that CAPRI is ba-
sally inactive in the cell but deactivates Ras-GTP at the plas-
ma membrane after Ca2þ-triggered membrane recruitment of
CAPRI (unpublished). The likely reason for CAPRI’s lack of
in vitro enhancement of the Ras GTPase reaction is a require-
ment for Ca2þ-dependent interactions with the plasma mem-
brane, suggesting that CAPRI is locked in an inactive con-
formation in the cytosol until translocation is induced (Fig. 2).
This hypothesis is entirely consistent with the in vivo data.
RASAL is highly related to CAPRI (59% identical) and is a
member of the GAP1 family that is strongly expressed in
endocrine tissues [46], in contrast to CAPRI where transcript
is widely expressed (data unpublished). Like CAPRI, RASAL
functions as a Ca2þ-triggered Ras GAP, dynamically respond-
ing to Ca2þ signals through the regulated association with the
plasma membrane (unpublished). It seems quite remarkable
that cells have developed at least two di¡erent Ca2þ sensors
tuned to detect Ca2þ and regulate the activation state of Ras.
Currently CAPRI and RASAL are two of the most dynam-
ically regulated GAPs for any small GTPase so far character-
ised. A physiological basis for having such a form of Ras
regulation is unclear, yet the recent discovery of PLCO as a
Ras e¡ector may go some way to providing an answer (see
below).
4. Ca2+/calmodulin as a brake on K-Ras activation
GEFs and GAPs regulate the Ras GTPase cycle by Ca2þ
(and DAG). However, it is also known that Ca2þ/calmodulin
directly regulates the activity of some Ras isoforms. This was
discovered during observations that the calmodulin inhibitor
W13 caused elevated Ras-GTP levels, sustained activation of
ERKs and prolonged p21cip1 expression in low-serum NIH
3T3 cells [47]. Later it was shown that calmodulin inhibition
caused preferential activation of K-Ras, and that in vitro K-
Ras-GTP bound directly and speci¢cally to calmodulin in a
Ca2þ-dependent manner [48]. Stimulation of ERK and Ras
signalling by calmodulin inhibition under conditions of low
serum was dependent on the action of PKC, suggesting that
calmodulin operates as a brake on PKC-dependent Ras acti-
vation by an unde¢ned mechanism that could result from
interfering with direct phosphorylation of K-Ras or an in£u-
ence on PKC-dependent Ras GAP activity [49].
5. Perspective: is PLCO the missing link?
Speci¢c mechanisms have evolved to directly regulate Ras
activity by Ca2þ and DAG, suggesting that Ras must have a
key role in this arm of cell signalling. There are a limited
number of reports in the literature that implicate oncogenic
Ras in the control of Ca2þ oscillation frequency but the mech-
anisms lack detail [50,51]. Observations that Ras-transformed
cells have elevated phosphoinositide metabolism have been
hotly debated over the years [52] but the discovery of PLCO
as a new class of PLC and Ras/Rap e¡ector [53^55] could go
a long way to resolving this disputed area of Ras biology. The
Fig. 2. Ca2þ-triggered translocation of CAPRI. Live HeLa cells expressing a fusion protein of green £uorescent protein (GFP) and CAPRI
were imaged by rapid microscopy using a Perkin Elmer UltraVIEW system. Cells were stimulated with the cholinergic agonist carbachol to mo-
bilise intracellular Ca2þ (time= seconds after stimulation). Membrane translocation induces the activation of CAPRI as a Ras GAP (unpub-
lished and [45]).
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existence of PLCO may also provide a reason for the cellular
battery of dynamic Ca2þ- and DAG-dependent GEFs and
GAPs that have recently been discovered. PLCO contains
both a CDC25 homology GEF domain and a pair of Ras
association (RA) domains, with the RA2 domain binding
Ras-GTP to stimulate enzymatic activity [55]. Yet, the regu-
lation of PLCO is highly complex since GK12 [54] and GLQ [56]
activate PLCO independently of Ras, and PLCO appears to
operate bifunctionally as a Ras [54] or Rap1 GEF [57]. It
may be that as a Ras/Rap e¡ector, PLCO will be demonstrated
to play a key role in the interplay between Ras and Rap
signalling and the co-ordinated generation of DAG and IP3.
If this proves to be the case, speci¢city and ¢delity within this
pathway can be provided by the highly dynamic spatio-tem-
poral regulation of Ca2þ- and DAG-regulated GEFs, GAPs
and PKCs. Therefore, depending on the cellular make-up and
signalling context, two major ‘products’ of PLC signalling can
enable feed-forward or feedback control of the Ras/Rap-PLC
signalling cassette (Fig. 3).
A long-standing issue in the Ca2þ signalling ¢eld revolves
around the cellular functions of physiological, complex Ca2þ
signals. How is information encoded by di¡erent modes of
Ca2þ signal [58]? Some of the most seductive demonstrations
of Ca2þ information processing have been at the level of gene
transcription, particularly the observations that Ca2þ signal
frequency determines the e⁄ciency of nuclear factor of acti-
vated T cells (NFAT)-induced transcription [59,60]. NFAT-
driven transcription also depends on an input from Ras [61]
but a role for repetitive Ca2þ signals in the control of Ras
activity has yet to be reported. There is no doubt that Ras
signalling is remarkably complex with cross-talk from multi-
ple receptors and within e¡ector pathways. Nevertheless, we
propose that the binary GTPase switch is ideally suited to be
a focal point for information processing by Ca2þ, particularly
for decoding frequency- and amplitude-modulated Ca2þ sig-
nals known to in£uence gene expression. In the future it will
be interesting to see what role PLCO may play in these pro-
cesses. Thus, old observations and areas of dispute over the
role of Ras within phosphoinositide signalling are beginning
to integrate and converge, as new Ras e¡ectors and new tar-
gets for Ras regulation by DAG and Ca2þ are discovered.
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